BIODEXA PHARMACEUTICALS-ADR
BDRX · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.42
- Today’s Low
- $0.33
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.47
- Previous Close
- $0.38
- Volume
- 266.6K
- Market Cap
- $473.57K
- P/E Ratio
- --
- EPS
- $0.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1 CASPIAN POINT, CARDIFF, UNITED KINGDOM, CF10 4DQ
- Country
- GB
- Listing Date
- 2014-12-08
- Fiscal Year End
- December
- Shares Outstanding
- 102.9B
- CIK
- 0001643918
- Website
- www.biodexapharma.com
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in the United Kingdom, rest of Europe, and internationally. The company is headquartered in Cardiff, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
--
2025-12-31
--
2025-06-30
--
2025-03-31
--
Operating Expenses
2026-06-30
$4.66M
2025-12-31
$4.67M
2025-06-30
$2.35M
2025-03-31
$1.72M
Net Income
2026-06-30
-$1.87M
2025-12-31
-$2.56M
2025-06-30
-$3.8M
2025-03-31
-$2.42M
Net Profit Margin
2026-06-30
--
2025-12-31
--
2025-06-30
--
2025-03-31
--
Earnings Per Share
2026-06-30
$0.00
2025-12-31
--
2025-06-30
$-15.06
2025-03-31
$-36.54
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.66M
2025-12-31
-$4.67M
2025-06-30
-$3.87M
2025-03-31
-$4.85M
Effective Tax Rate
2026-06-30
-2.44%
2025-12-31
-2.38%
2025-06-30
-4.15%
2025-03-31
4.9%
| Item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | -- | -- | -- | -- |
| Operating Expenses | $4.66M | $4.67M | $2.35M | $1.72M |
| Net Income | -$1.87M | -$2.56M | -$3.8M | -$2.42M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $0.00 | -- | $-15.06 | $-36.54 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.66M | -$4.67M | -$3.87M | -$4.85M |
| Effective Tax Rate | -2.44% | -2.38% | -4.15% | 4.9% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.